The FDA approved lisdexamfetamine, a Vyvanse generic, in August 2024. Lisdexamfetamine, along with many other ADHD medications, is currently also in shortage.
Reason for the Shortage. Alvogen has lisdexamfetamine capsules on shortage due to an issue with the active ingredient. Amneal has lisdexamfetamine capsules
October 2024 – National shortage of ADHD medication: Patient Information Leaflet – National supply shortage of Lisdexamfetamine (Elvanse) capsules.
Reason for the Shortage Alvogen has lisdexamfetamine capsules on shortage due to an issue with the active ingredient. Amneal has lisdexamfetamine capsules on
(lisdexamfetamine dimesilate). Currently there are shortages of ⚠️Medicine shortage – Vyvanse (lisdexamfetamine dimesilate) capsules⚠️
On J, TGA reported that certain strengths of lisdexamfetamine medications remain in shortage. In February 2024, Australia
shortage, there are 5 new drug supply issues in 2024, including Diazepam, Lenalidomide, Lisdexamfetamine, and Mercaptopurine.
shortages as of late 2024. The medications facing shortages include methylphenidate, lisdexamfetamine, guanfacine, and atomoxetine, with
shortage-alerts/shortages-vyvanse-lisdexamfetamine-dimesilate-capsules
Comments